Barry Molchadsky, MBA - CEO

In recent years, Barry has been working in the field of sleep health in collaboration with the world's leading research institutions, with an emphasis on building a strong patent portfolio, manufacturing infrastructure and distribution channels.

Barry has 15 years of experience in the capital markets through leading investment firms. He was one of the founders of the Top Alfa Investment House and founded IBI Trade as part of the IBI Investment House. In the past Barry worked at Mizrahi Bank in the risk management department for the capital market.

Mark Shachar, Msc – CTO

Mark has 17 years of professional career. Co-founder of “Apex R&D” – A multi-disciplinary product development. The company manages entire projects from initial proof of concept through the design and prototype phases of requirements, design documents and implementation, all the way to final product delivery. Founded several biomedical companies (Laparoscopy, Lung physiology). Specializes in physiological signal processing, biomechanics, micro surgery, noise reduction and thermal design. Supervising and training teams of engineers and designers in a teamwork environment of more than 130 projects. Main field of work involves simulations of mechanical stress, vibration, thermodynamics and multi-phase flow.

Advisory board

Prof. Asher Tal, MD.

Asher is a Professor (Emeritus) of Pediatrics and Founder of Pediatric Pulmonary Unit and sleep laboratory at Soroka Medical Center, Ben – Gurion University of the Negev, Beer-Sheva, Israel. Professor Tal authored or co-authored over 100 publications, many of them involve sleep medicine. His research interests include sleep-disordered breathing, pediatric and adult obstructive sleep apnea syndrome and insomnia, as well as childhood asthma, bronchiolitis and wheezing in infancy. Currently, Prof. Tal is the Medical Director of Millennium Sleep Laboratory and Sleep Medicine Clinic in Beer-Sheva, Israel.

Dr. Dov Melamed, PHD.

Co-Founder of Periness LTD and Oshadi LTD, Non-Executive Director of XTL Biopharmaceuticals and former president of SciVac. Researcher at Bar-Ilan University’s male fertility clinic and QBI. He is a biotech entrepreneur with over 10 years of experience in the life science industry. He has demonstrated success in taking drugs from the lab to the shelf by identifying target markets, planning regulatory strategy, raising capital, executing clinical trials and scaling up to commercial production.

Ron Mekler, CPA, MBA.

During the last 15 years Ron has been serving in key positions in leading Israeli companies: CFO at a large health services organizations (more than 2,000 employees, 600K customers). Controller in several international industrial and real estate companies.